Oligonucleotide IMT504 reduces neuropathic pain after peripheral nerve injury

Neuroscience Letters

Volumn 444, Issue 1, 2008, Pages 69-73

  Coronel, María Florencia ^a   Hernando Insúa, Andrés ^b   Rodriguez, Juan Manuel ^b   Elias, Fernanda ^b   Chasseing, Norma Alejandra ^c   Montaner, Alejandro Daniel ^b   Villar, Marcelo José ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b Immunotech SA   (Argentina)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Bone marrow stromal cells; Mechanical and thermal allodynia; Mesenchymal stem cells; Oligodeoxinucleotides; Sciatic nerve crush

Indexed keywords

IMT 504; OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOI TEST; CONTROLLED STUDY; EXPERIMENTAL TEST; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NEUROPATHY; SENSORY STIMULATION; VON FREY TEST;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; MALE; OLIGODEOXYRIBONUCLEOTIDES; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NEUROPATHY; STROMAL CELLS; TIME FACTORS;

EID: 50849110151     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.07.045     Document Type: Article

References (32)

1. Arinzeh T.L., Peter S.J., Archambault M.P., van den Bos C., Gordon S., Kraus K., Smith A., and Kadiyala S. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. Am. 85 (2003) 1927-1935
2. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
3. Bonilla S., Silva A., Valdes L., Geijo E., Garcia-Verdugo J.M., and Martinez S. Functional neural stem cells derived from adult bone marrow. Neuroscience 133 (2005) 85-95
4. Chaplan S., Bach F., Pogrel J., Chung J., and Yaksh T. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. 16 (1994) 7711-7724
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., and Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
6. Choi Y., Yoon Y.W., Na H.S., Kim S.H., and Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59 (1994) 369-376
7. Chopp M., Zhang X.H., Li Y., Wang L., Chen J., Lu D., Lu M., and Rosenblum M. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11 (2000) 3001-3005
8. Coronel M.F., Musolino P.L., and Villar M.J. Selective migration and engraftment of bone marrow mesenchymal stem cells in rat lumbar dorsal root ganglia after sciatic nerve constriction. Neurosci. Lett. 405 (2006) 5-9
9. Cova L., Ratti A., Volta M., Fogh I., Cardin V., Corbo M., and Silani V. Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation. Stem Cells Dev. 13 (2004) 121-131
10. Cuevas P., Carceller F., García Gomez I., Yan M., and Dujovny M. Bone marrow stromal cell implantation for peripheral nerve repair. Neurol. Res. 26 (2004) 230-232
11. Elías F., Fló J., López R.A., Zorzopulos J., Montaner A., and Rodríguez J.M. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J. Immunol. 171 (2003) 3697-3704
12. Elías F., Fló J., Rodríguez J.M., De Nichilo A., López R.A., Zorzopulos J., Nagle C., Lahoz M., and Montaner A. PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 response. Vaccine 23 (2005) 3597-3603
13. Galluzi K.E. Management of neuropathic pain. JAOA 105 (2005) 12-19
14. Gilron I., Watson C.P.N., Cahill C.M., and Moulin D.E. Neuropathic pain: a practical guide for the clinician. CMAJ 175 (2006) 265-275
15. Halme D.G., and Kessler D.A. FDA regulation of stem-cell-based therapies. New Engl. J. Med. 355 (2006) 1730-1735
16. Hernando Insúa A., Montaner A.D., Rodríguez J.M., Elías F., Fló J., López R.A., Zorzopulos J., Hofer E.L., and Chasseing N.A. IMT, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases in the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy. Stem Cells 25 (2007) 1047-1054
17. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz González X.R., Reyes M., Lenvick T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada W.A., and Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
18. Juliano R., Alam R., Dixit V., and Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36 (2008) 4158-4171
19. Lange C., Tögel F., Ittrich H., Clayton F., Nolte-Ernsting C., Zander A.R., and Westenfelder C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 68 (2005) 1613-1617
20. Lu D., Mahmood A., Wang L., Li Y., Lu M., and Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12 (2001) 559-563
21. Mahmood A., Lu D., and Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 21 (2004) 33-39
22. Mannello F., and Tonti G.A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture. Stem Cells 25 (2007) 1603-1609
23. Mimeault M., and Batra S.K. Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 24 (2006) 2319-2345
24. Musolino P.L., Coronel M.F., Hökfelt T., and Villar M.J. Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci. Lett. 418 (2007) 97-101
25. Ohta M., Suzuki Y., Noda T., Ejiri Y., Dezawa M., Kataoka K., Chou H., Ishikawa N., Matsumoto N., Iwashita Y., Mizuta E., Kuno S., and Ide C. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 187 (2004) 266-278
26. Piao H., Youn T.J., Kwon J.S., Kim Y.H., Bae J.W., Bora-Sohn S., Kim D.W., Cho M.C., Lee M.M., and Park Y.B. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur. J. Heart Fail. 7 (2005) 730-738
27. Price M.J., Chou C.C., Frantzen M., Miyamoto T., Kar S., Lee S., Shah P.K., Martin B.J., Lill M., Forrester J.S., Chen P.S., and Makkar R.R. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int. J. Cardiol. 111 (2006) 231-239
28. Rayburn E.R., and Zhang R. Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?. Drug Discov. Today 11 (2008) 513-521
29. Rodríguez J.M., Elías F., Montaner A., Fló J., López R.A., Zorzopulos J., Franco R.J., Lenial S.P., López Salón M., Pirpignani M.L., Solimano J., Garay G., Riveros D., Fernandez J., Cacchione R., and Dupont J. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells. Medicina (Buenos Aires) 66 (2006) 9-16
30. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., and Simmons P.J. Mesenchymal stem cells. Arch. Med. Res. 34 (2003) 565-571
31. Tatebe M., Nakamura R., Kagami H., Okada K., and Ueda M. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit. Cytotherapy 7 (2005) 520-530
32. Zietlow R., Lane E.L., Dunnett S.B., and Rosser A.E. Human stem cells for CNS repair. Cell Tissue Res 331 (2008) 301-322